Critical Care

official impact factor 4.60

This article is part of the supplement: Severe sepsis and drotrecogin alfa (activated)

Highly Access

Practical aspects of treatment with drotrecogin alfa (activated)

Luigi Camporota and Duncan Wyncoll*

Critical Care 2007, 11(Suppl 5):S7 doi:10.1186/cc6158

Accesses  

  • Last 30 days: 52 accesses
  • Last 365 days: 719 accesses
  • All time: 6795 accesses